Log in with your email address username.


[Correspondence] PRIMA, non nocere: a reply from the authors

We thank John Harvin and Lillian Kao for their Comment1 on our Article.2 Harvin and Kao stated, on the basis of the results of the PRIMA trial, that we cannot conclude that there are no increased short-term risks associated with use of prophylactic mesh. The short-term results were published in Annals of Surgery in 2015,3 and it is true that we did not specifically power our study with the short-term outcomes in mind.